INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE);SORBONNE UNIVERSITÉ;APHP (ASSISTANCE PUBLIQUE;PARIS SCIENCES ET LETTRES - QUARTIER LATIN;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
发明人:
Nathalie ROUACH,Eléna DOSSI,Gilles HUBERFELD
申请号：
US16630114
公开号：
US20200163916A1
申请日:
2018.07.13
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Probenecid or a pharmaceutical acceptable salt thereof for use in the treatment of a neurological disorder in a subject in need thereof, wherein administration of probenecid or a pharmaceutical acceptable salt thereof controls clinical or electrographic seizures in the subject. Preferably, the neurological disorder is an epileptic disease, disorder or condition.
